1. Home
  2. EEFT vs LGND Comparison

EEFT vs LGND Comparison

Compare EEFT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EEFT
  • LGND
  • Stock Information
  • Founded
  • EEFT 1994
  • LGND 1987
  • Country
  • EEFT United States
  • LGND United States
  • Employees
  • EEFT N/A
  • LGND 68
  • Industry
  • EEFT EDP Services
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • EEFT Technology
  • LGND Health Care
  • Exchange
  • EEFT Nasdaq
  • LGND Nasdaq
  • Market Cap
  • EEFT 3.5B
  • LGND 3.2B
  • IPO Year
  • EEFT 1997
  • LGND 1992
  • Fundamental
  • Price
  • EEFT $70.43
  • LGND $201.87
  • Analyst Decision
  • EEFT Strong Buy
  • LGND Strong Buy
  • Analyst Count
  • EEFT 5
  • LGND 8
  • Target Price
  • EEFT $117.60
  • LGND $144.71
  • AVG Volume (30 Days)
  • EEFT 1.0M
  • LGND 139.7K
  • Earning Date
  • EEFT 10-22-2025
  • LGND 08-05-2025
  • Dividend Yield
  • EEFT N/A
  • LGND N/A
  • EPS Growth
  • EEFT N/A
  • LGND N/A
  • EPS
  • EEFT 6.78
  • LGND N/A
  • Revenue
  • EEFT $4,182,800,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • EEFT $9.05
  • LGND $18.41
  • Revenue Next Year
  • EEFT $7.49
  • LGND $18.87
  • P/E Ratio
  • EEFT $10.42
  • LGND N/A
  • Revenue Growth
  • EEFT 7.25
  • LGND 53.40
  • 52 Week Low
  • EEFT $68.81
  • LGND $81.74
  • 52 Week High
  • EEFT $114.25
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • EEFT 20.48
  • LGND 60.86
  • Support Level
  • EEFT $71.14
  • LGND $201.50
  • Resistance Level
  • EEFT $73.26
  • LGND $212.49
  • Average True Range (ATR)
  • EEFT 1.88
  • LGND 8.11
  • MACD
  • EEFT -0.30
  • LGND 0.34
  • Stochastic Oscillator
  • EEFT 12.88
  • LGND 63.34

About EEFT Euronet Worldwide Inc.

Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: